LYVE-1 Antibodies
LYVE-1 (Lymphatic Vessel Endothelial Receptor 1) is a receptor for the extracellular matrix mucopolysaccharide hyaluronan and is primarily expressed by lymphatic endothelial cells. LYVE-1 is synthesized as a protein of 322 amino acids in length with a theoretical molecular weight of 35 kDa, although due to O-glycosylation often appears in SDS-PAGE at a molecular weight ranging from ~60-70 kDa. We offer several antibodies to detect LYVE-1 that have been cited in 105+ publications with multiple 4- and 5-star reviews. Browse our extensive catalog for recombinant monoclonal antibodies, monoclonal antibodies, polyclonal antibodies, and LYVE-1-conjugated antibodies. Our LYVE-1 antibodies have been validated for multiple research applications including Block/Neutralize, CyTOF-ready, ELISA, Flow Cytometry, ICC, Immunofluorescence, IHC-Frozen, IHC-Paraffin, and Western Blot. These LYVE-1 antibodies are suitable for use in Human, Mouse, and Rat. Each LYVE-1 antibody is fully covered by Novus’ Guarantee+ to give you peace of mind and support when you need it. Choose the anti-LYVE-1 antibody best suited for your research needs by viewing the technical details, images, references, reviews, and related products.
Alternate Names for LYVE-1 Antibodies
anti-LYVE-1 antibody, anti-LYVE1 antibody, anti-cell surface retention sequence binding protein-1 antibody, anti-Cell surface retention sequence-binding protein 1 antibody, anti-CRSBP-1 antibody, anti-CRSBP1 antibody, anti-extracellular link domain containing 1 antibody, anti-extracellular link domain-containing 1 antibody, anti-Extracellular link domain-containing protein 1 antibody, anti-HAR antibody, anti-Hyaluronic acid receptor antibody, anti-lymphatic vessel endothelial hyaluronan receptor 1 antibody, anti-lymphatic vessel endothelial hyaluronic acid receptor 1 antibody, anti-LYVE-1XLKD1 antibody
27 Results for "lyve-1" in Primary Antibodies
![Immunohistochemistry-Paraffin: LYVE-1 Antibody [NB600-1008] - Positive staining for Lyve-1 on FFPE Mouse Liver, 20x magnification. Antibody diluted 1:800. Image from verified customer review.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-Paraffin-NB600-1008-img0050.jpg "Immunohistochemistry-Paraffin: LYVE-1 Antibody [NB600-1008] - Positive staining for Lyve-1 on FFPE Mouse Liver, 20x magnification. Antibody diluted 1:800. Image from verified customer review.")
![Immunohistochemistry-Paraffin: LYVE-1 Antibody [NB600-1008] - Mouse kidney stained with LYVE-1 antibody. Image from verified customer review.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-Paraffin-NB600-1008-img0047.jpg)
![Western Blot: LYVE-1 Antibody [NB600-1008] - Analysis of anti-mouse LYVE-1. Sample was loaded in 15% SDS-polyacrylamide gel under reducing conditions.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB600-1008-img0030.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB600-1008] - Zeb1-regulation of alkali-induced corneal NV in mice. c1 A representative stereoscopic image of the Zeb1-/+ and d1 Zeb1+/+ corneas and c2-d2 their whole flat-mount corneas immunostained with the endothelium marker CD31 and the lymphatic vessel marker LYVE-1. *p = 0.05; **p = 0.01. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32620870/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/LYVE-1 Antibody-Immunohistochemistry-NB600-1008-img0057.jpg)
![Immunohistochemistry-Paraffin: LYVE-1 Antibody [NB600-1008] - Mouse liver. Antibody at 1:800. Detection by Polymer-HRP. Image from verified customer review.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-Paraffin-NB600-1008-img0051.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB600-1008] - Hypoxia, blood vessel and proliferation staining. IHC staining in the Biopsy 23 and Biopsy 3 respectively for CA-9, EF5, CD31, Ki67 and LYVE1. 15x Magnification. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/2072-6694/4/3/821), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-NB600-1008-img0052.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB600-1008] - Zeb1-regulation of alkali-induced corneal NV in mice.a Reduction of Zeb1 mRNA in the heterozygous Zeb−/+ corneas compared to the homozygous Zeb1+/+ corneas. b Significant NV score & vessel size reduction in the Zeb1−/+ corneas as compared to their Zeb1+/+ siblings. c1 A representative stereoscopic image of the Zeb1−/+ & d1 Zeb1+/+ corneas & c2–d2 their whole flat-mount corneas immunostained with the endothelium marker CD31 & the lymphatic vessel marker LYVE-1. *p ≤ 0.05; **p ≤ 0.01. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32620870), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1008_rabbit-polyclonal-lyve-1-antibody-31020241535663.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB600-1008] - Zeb1-regulation of alkali-induced corneal NV in mice.a Reduction of Zeb1 mRNA in the heterozygous Zeb−/+ corneas compared to the homozygous Zeb1+/+ corneas. b Significant NV score & vessel size reduction in the Zeb1−/+ corneas as compared to their Zeb1+/+ siblings. c1 A representative stereoscopic image of the Zeb1−/+ & d1 Zeb1+/+ corneas & c2–d2 their whole flat-mount corneas immunostained with the endothelium marker CD31 & the lymphatic vessel marker LYVE-1. *p ≤ 0.05; **p ≤ 0.01. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32620870), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1008_rabbit-polyclonal-lyve-1-antibody-310202415175280.jpg)
![Western Blot: LYVE-1 Antibody [NB100-725] - Western Blot: [NB100-725] - Total protein from human stomach, lymph node and placenta was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml anti-LYVE1 in 1% milk, and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB100-725-img0027.jpg "Western Blot: LYVE-1 Antibody [NB100-725] - Western Blot: [NB100-725] - Total protein from human stomach, lymph node and placenta was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml anti-LYVE1 in 1% milk, and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: LYVE-1 Antibody [NB100-725] - Analysis using the DyLight 488 conjugate of NB100-725. Staining of LYVE1 in paraffin embedded MDA-MB-231 breast cancer orthotopic transplantation tissue. Image courtesy of product review submitted by Luana Schito.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-Paraffin-NB100-725-img0028.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB100-725] - Detection of LYVE1 in endothelial cells of human lung blood vessels using NB100-725. Note presence of RBCs within vessel lumen.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-NB100-725-img0011.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - Analysis using the DyLight 488 conjugate of NB100-725. Unlabeled control with labeled samples of cells dissociated mechanically and enzymatically from human skin. Image provided via product review by Patricia Redondo.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0024.jpg)
![Western Blot: LYVE-1 Antibody [NB100-725] - Analysis of extracts from A549 cells using LYVE1 antibody (NB100-725, 1:100). Image from verified customer review.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB100-725-img0018.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - LYVE1 antibody was tested at 1:400 in A549 cells using an Alexa Fluor 488 secondary (shown in green) alongside unstained cells (shown in red).](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0016.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - An intracellular stain was performed on A549 cells with LYVE-1 Antibody NB100-725 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550 (SA5-10033, Thermo Fisher).](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0031.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB100-725] - Detection of LYVE1 in endothelial cells of human bladder vasculature using NB100-725.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-NB100-725-img0012.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB100-725] - Detection of LYVE1 in endothelial cells of human lung blood vessels using NB100-725.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-NB100-725-img0013.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - Analysis using the Alexa Fluor (R) 488 conjugate of NB100-725. Staining of LYVE1 in human dissociated skin lyve1+ using AF488 conjugated anti-LYVE1 antibody. Image from verified customer review.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0023.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - An intracellular stain was performed on A549 cells with LYVE-1 Antibody NB100-725G (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Dylight 488.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0029.jpg)
![Flow Cytometry: LYVE-1 Antibody [NB100-725] - An intracellular stain was performed on K562 cells with LYVE-1 Antibody NB100-725C (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to DyLight 650.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB100-725-img0030.jpg)
![Immunohistochemistry: LYVE-1 Antibody [NB600-1005] - LYVE1 Antibody [NB600-1005] - Staining of human skin showing positivity in lymphatic vessels. Image provided by Patricia Redondo.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Immunohistochemistry-NB600-1005-img0011.jpg "Immunohistochemistry: LYVE-1 Antibody [NB600-1005] - LYVE1 Antibody [NB600-1005] - Staining of human skin showing positivity in lymphatic vessels. Image provided by Patricia Redondo.")
![Flow Cytometry: LYVE-1 Antibody [NB600-1005] - Analysis with primary human dermal microvascular endothelial cells (HDMVEC).](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Flow-Cytometry-NB600-1005-img0010.jpg)
![Western Blot: LYVE-1 Antibody [NB600-1005] - Analysis of recombinant human sLYVE-1 and mouse sLYVE-1 using an anti-human LYVE-1 polyclonal antibody directed against the extracellular domain of human LYVE-1. There is more or less no cross reactivity withmouse LYVE-1.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB600-1005-img0009.jpg)
![Immunohistochemistry: LYVE-1 Antibody (RM0033-4D17) [NB110-61026] - a-d As revealed by IHC, E12.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). DAPI marks the nuclei in blue (d). Scale=30 um. n=3 brains. e-h E13.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). DAPI marks the nuclei in blue (h). Scale=30 um. n=3 brains. i-l E18 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). PROX1 is cytoplasmic (j, red arrows) in the meninges but nuclear in neurons (j, blue arrows). DAPI marks the nuclei in blue (l). Scale=30 um. n=3 brains. Image collected and cropped by CiteAb from the following publication (link.springer.com/10.1007/s00401-019-02091-z), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-RM0033-4D17-Immunohistochemistry-NB110-61026-img0004.jpg "Immunohistochemistry: LYVE-1 Antibody (RM0033-4D17) [NB110-61026] - a-d As revealed by IHC, E12.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). DAPI marks the nuclei in blue (d). Scale=30 um. n=3 brains. e-h E13.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). DAPI marks the nuclei in blue (h). Scale=30 um. n=3 brains. i-l E18 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), and MRC1 (white). PROX1 is cytoplasmic (j, red arrows) in the meninges but nuclear in neurons (j, blue arrows). DAPI marks the nuclei in blue (l). Scale=30 um. n=3 brains. Image collected and cropped by CiteAb from the following publication (link.springer.com/10.1007/s00401-019-02091-z), licensed under a CC-BY license.")
![Immunohistochemistry: LYVE-1 Antibody (RM0033-4D17) [NB110-61026] - Cells of human meninges co-express LLEC markers. DAB-IHC with single antibody detecting LYVE1 (b), in the meninges of human post mortem brain showing no signs of neuropathology. These images are taken from a 38 year old male (sample P17/07), and confirmed in n = 2 additional samples. P parenchyma. Scale = 40 um. DAB-IHC with single antibody detecting LYVE1 (c), in elderly human meninges (age: 89-92) with evidence of neuropathology and confirmed in n = 3 brains. P, parenchyma. Scale = 20 um. Image collected and cropped by CiteAb from the following publication (link.springer.com/10.1007/s00401-019-02091-z), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-RM0033-4D17-Immunohistochemistry-NB110-61026-img0005.jpg)
![Immunohistochemistry-Paraffin: LYVE1 Antibody (RM0033-4D17) [NB110-61026] - 4% PFA fixed and paraffin embedded mouse Lung and Heart tissue section was subjected to IHC staining of mouse LYVE-1.](http://images.novusbio.com/fullsize/LYVE1-Antibody-RM0033-4D17-Immunohistochemistry-Paraffin-NB110-61026-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (RM0033-4D17) - Azide and BSA Free [NB110-61026] - Mouse LLECs develop independent of the transcription factor PU.1. a–d As detected by IHC, E15.5 wild-type mice have cells that co-express LYVE1 (a, red) PROX1 (b, green) & MRC1 (c, white) in the developing meninges (white bracket). DAPI labels nuclei blue in the merged image (d). White arrows indicate cells with these three markers. Scale = 50 µm. n = 2 brains. e–h) The meninges (white bracket) of E15.5 PU.1 knockout siblings contain many cells (white arrows) that co-express LYVE1 (e, red), PROX1 (f, green), & MRC1 (g, white). Scale = 50 µm. n = 3 brains Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31696318), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-61026_rat-monoclonal-lyve-1-antibody-rm0033-4d17-31020241534313.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (RM0033-4D17) - Azide and BSA Free [NB110-61026] - Mouse LLECs take up A beta 1-40. a Schematic showing the site of dye & A beta 1-40 perfusion into the CSF via the cisterna magna (arrow) of a 2-month old mouse. The dotted line indicates the plane of section. A anterior, P posterior, D dorsal, V ventral. b Coronal brain section indicating the areas imaged. SF4 refers to area captured in Figure S4. c The percentage of each labelled cell type that internalized perfused A beta . Cells co-expressing VEGFR3 & LYVE1 take up A beta at a higher rate than MRC1, LYVE1 double-positive cells as well as MRC1-positive, LYVE1-negative cells (p ≤ 0.05, bootstrap). VEGFR3, LYVE1 counts, n = 2 brains (3 sections/brain). MRC1, LYVE1 counts, n = 3 brains (3 sections/brain). d–d′′′ Cells of the adult mouse meninges that co-express VEGFR3 (d, green) & LYVE1 (d′, white) internalize A beta 1-40 (d′′, cyan). Scale = 20 µm. e-e′′′) Cells of the adult mouse meninges that co-express VEGFR3 (e, green) & MRC1 (e′, white) internalize A beta 1-40 (e′′, cyan). Scale = 40 µm. f–f′′′) Cells of the adult mouse meninges that co-express MRC1 (f, magenta) & LYVE1 (f′, white) internalize A beta 1-40 (f′′, cyan). The walls of a blood vessel (white arrowhead, f′′) also accumulate A beta 1-40. Scale = 60 µm Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31696318), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-61026_rat-monoclonal-lyve-1-antibody-rm0033-4d17-31020241621825.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (RM0033-4D17) - Azide and BSA Free [NB110-61026] - Cells with BLEC molecular markers are present within the mouse leptomeninges. a Coronal brain section of adult zebrafish brain indicating the imaging area in the dorsal optic tectum (TeO). b A 14 month old Tg(kdr-l:mCherry); Tg(flt4:mCitrine) double transgenic zebrafish has cells in the meninges (white bracket) that express flt4/vegfr3 ( alpha -GFP, green) near kdr-l positive ( alpha -RFP, red) blood vessels. DAPI (blue) labels the nuclei. Scale = 50 µm. c Coronal mouse brain section showing the imaging areas of the meninges. d As revealed by IHC, 17-week-old mouse brains express VEGFR3 (green) in the meninges (white bracket). Tie2-GFP;NG2-DsRed double reporter mice were used to distinguish arteries & veins. NG2 (red) labels pericytes & smooth muscle cells, Tie2 (magenta) labels vascular endothelial cells, & Hoechst (blue) stains nuclei. The image is rotated with the parenchyma at the bottom for ease of comparison with panel b. Scale = 50 µm. e-e′′′ As revealed by IHC, cells of the meninges co-express MRC1 (e, yellow), LYVE1 (e′, white), & VEGFR3 (e′′, green). Red arrows highlight cells expressing these three markers. The images are rotated with the parenchyma at the bottom. scale = 30 µm. f, g Quantification of the relative numbers of single & double-labelled cells in 2-month old mouse meninges. VEGFR3 & LYVE1 cell counts were from n = 2 brains, 3 coronal sections (10 area images)/brain. MRC1 & LYVE1 cell counts were from n = 3 brains, 3 coronal sections (4 area images)/brain. The mean values for each set are depicted Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31696318), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-61026_rat-monoclonal-lyve-1-antibody-rm0033-4d17-310202416203723.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (RM0033-4D17) - Azide and BSA Free [NB110-61026] - Cells of human meninges co-express LLEC markers. a–c DAB-IHC with single antibodies detects VEGFR3 (a), LYVE1 (b), & MRC1 (c) in the meninges of human post mortem brain showing no signs of neuropathology. These images are taken from a 38 year old male (sample P17/07, Table 1), & confirmed in n = 2 additional samples. P parenchyma. Scale = 150 µm (a); 40 µm (b); & 20 µm (c). d–f DAB-IHC with single antibodies detects VEGFR3 (b), LYVE1 (c), & MRC1 (d) in elderly human meninges (age: 89–92) with evidence of neuropathology & confirmed in n = 3 brains (Table 1). P, parenchyma. Scale = 20 µm. g–p IHC with fluorescent antibodies detects human meningeal cells that co-express MRC1 (h, m, yellow), LYVE1 (i, n, white), & VEGFR3 (j, o, green). Nuclei/RNA are labelled with DAPI (g, l, blue) & images are merged in (k, p). Scale = 10 µm Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31696318), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-61026_rat-monoclonal-lyve-1-antibody-rm0033-4d17-310202416205169.jpg)
![Immunocytochemistry/ Immunofluorescence: LYVE-1 Antibody (RM0033-4D17) - Azide and BSA Free [NB110-61026] - Cells expressing LLEC markers are present within embryonic mouse leptomeninges. a–d As revealed by IHC, E12.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), & MRC1 (white). DAPI marks the nuclei in blue (d). Scale = 30 µm. n = 3 brains. e–h E13.5 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), & MRC1 (white). DAPI marks the nuclei in blue (h). Scale = 30 µm. n = 3 brains. i–l E18 mouse meninges (white bracket) contain cells that co-express LYVE1 (red), PROX1 (green), & MRC1 (white). PROX1 is cytoplasmic (j, red arrows) in the meninges but nuclear in neurons (j, blue arrows). DAPI marks the nuclei in blue (l). Scale = 30 µm. n = 3 brains Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31696318), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-61026_rat-monoclonal-lyve-1-antibody-rm0033-4d17-310202416205126.jpg)
![Western Blot: LYVE-1 Antibody [NB100-726] - Detection of LYVE-1 in recombinant human protein using NB 100-726. ECL detection overnight.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB100-726-img0006.jpg "Western Blot: LYVE-1 Antibody [NB100-726] - Detection of LYVE-1 in recombinant human protein using NB 100-726. ECL detection overnight.")
![Western Blot: LYVE-1 Antibody [NB100-726] - Detection of LYVE-1 in mouse spleen lysate using NB 100-726. ECL detection overnight.](http://images.novusbio.com/fullsize/LYVE-1-Antibody-Western-Blot-NB100-726-img0005.jpg)
